Prospects of Marine Sterols against Pathobiology of Alzheimer's Disease: Pharmacological Insights and Technological Advances

• Published in: Marine drugs Vol. 19; no. 3; p. 167
• Main Authors: Rahman, Md Ataur, Dash, Raju, Sohag, Abdullah Al Mamun, Alam, Mahboob, Rhim, Hyewhon, Ha, Hunjoo, Moon, Il Soo, Uddin, Md Jamal, Hannan, Md Abdul
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 20.03.2021; MDPI AG
• Subjects: cholesterol homeostasis; fucosterol; inflammation; marine steroids; neurodegeneration; oxidative stress; Review; marine steroids; neurodegeneration; cholesterol homeostasis; inflammation; oxidative stress; fucosterol
• ISSN: 1660-3397; 1660-3397
• DOI: 10.3390/md19030167

Alzheimer's disease (AD) is a degenerative brain disorder characterized by a progressive decline in memory and cognition, mostly affecting the elderly. Numerous functional bioactives have been reported in marine organisms, and anti-Alzheimer's agents derived from marine resources have gained attention as a promising approach to treat AD pathogenesis. Marine sterols have been investigated for several health benefits, including anti-cancer, anti-obesity, anti-diabetes, anti-aging, and anti-Alzheimer's activities, owing to their anti-inflammatory and antioxidant properties. Marine sterols interact with various proteins and enzymes participating via diverse cellular systems such as apoptosis, the antioxidant defense system, immune response, and cholesterol homeostasis. Here, we briefly overview the potential of marine sterols against the pathology of AD and provide an insight into their pharmacological mechanisms. We also highlight technological advances that may lead to the potential application of marine sterols in the prevention and therapy of AD.